Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 18
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/15/2007
1.
Phase III Randomized Study of ARA-C/DNR vs DHAD/VP-16 Induction Therapy Followed by ARA-C/DNR Consolidation Therapy in Older Patients with Previously Untreated Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
56 and over
NCI
SWOG-9333
Last Modified:
8/1/1998
 
First Published:
8/1/1998
2.
Phase III Randomized Study of Pentoxifylline, Ciprofloxacin, and Dexamethasone Versus Amifostine in Patients with Myelodysplastic Syndromes (Summary Last Modified 08/1998)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
21 and over
Pharmaceutical / Industry
BOSTON-VAMC-523
ALZA-97-047-ii, NCI-V98-1422
Last Modified:
7/5/2007
 
First Published:
5/1/1999
3.
Phase III Randomized Study of Ciprofloxacin vs Cephalexin in Patients with Stage Ta Transitional Cell Carcinoma of the Bladder Treated with Transurethral Tumor Resection
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
NCI
SWOG-S9809
CLB-S9809, NCT00003824, S9809
Last Modified:
9/1/1999
 
First Published:
4/1/1998
4.
Phase I/II Study of Docetaxel/Cisplatin/Fluorouracil/Leucovorin Calcium in Patients with Advanced Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck (Summary Last Modified 09/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
NCI
DFCI-97130
NCI-G98-1385
Last Modified:
6/1/1994
5.
Phase I/II Study of BU/CTX plus Autologous or Syngeneic Bone Marrow Transplantation or Peripheral Blood Stem Cell Rescue in Patients with Advanced Multiple Myeloma (Summary Last Modified 06/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 to 65
FHCRC-336.3
NCI-V88-0470
Last Modified:
12/1/1994
6.
Phase II Study of Anti-TNF Therapy with PTX and CPFX in Patients Undergoing Ablative Chemoradiotherapy/Allogeneic Bone Marrow Transplantation for AML in First or Second Remission or First Relapse (Summary Last Modified 12/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Closed
17 to 55
FHCRC-601.0
NCI-V94-0382
Last Modified:
5/10/2007
7.
Phase II Study of High-Dose CHOP (CTX/DOX/VCR/PRED) with G-CSF in Newly Diagnosed High-Risk non-Hodgkin's Lymphoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 to 65
NCI
CLB-9351
CALGB-9351
Last Modified:
4/1/1998
 
First Published:
3/1/1998
8.
Phase II Study of Docetaxel/Cisplatin/Leucovorin Calcium/Fluorouracil in Patients with Locally Advanced Squamous cell Carcinoma of the Head and Neck (Summary Last Modified 04/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
NCI
DFCI-96184
NCI-G98-1380
Last Modified:
6/1/1997
9.
Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Completed
any age
NCI
NCI-85-C-212C
NCI-T86-0036N, T86-0036
Last Modified:
9/1/1993
10.
Phase II Study of High-Dose CEP (CTX/VP-16/CDDP) with GM-CSF and anti-TNF Therapy with Pentoxifylline/Ciprofloxacin as Consolidation in Patients with High-Risk Ovarian Cancer (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
PSOC-1204
NCI-V93-0244
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute